US2015203464A1PendingUtilityA1

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

47
Assignee: TAKEDA PHARMACEUTICALPriority: Jan 27, 2010Filed: Apr 2, 2015Published: Jul 23, 2015
Est. expiryJan 27, 2030(~3.5 yrs left)· nominal 20-yr term from priority
Inventors:Naomi Kitamoto
A61P 35/00A61P 43/00A61P 39/00A61P 25/02A61P 25/00C07D 275/06C07D 257/04A61K 31/282A61K 31/4545A61K 31/41A61K 31/216C07D 249/06A61K 31/428A61K 31/337A61K 31/4196A61K 31/69C07C 311/28A61K 31/351A61K 31/4192C07D 309/28A61K 45/06A61K 31/235
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a medicament that suppresses (or mitigates) various neurological symptoms caused by a peripheral nerve disorder induced by an anti-cancer agent.

Claims

exact text as granted — not AI-modified
1 . Ethyl (3S)-3-[N-(2-chloro-4-fluorophenyl)sulfamoyl]-3,6-dihydro-2H-pyran-4-carboxylate or a salt thereof or a prodrug thereof.

Join the waitlist — get patent alerts

Track US2015203464A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.